|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2006-11-30
|
|
pubmed:abstractText |
Electrolyte impairments are common in hemodialysis (HD) patients. Consequently, QT dispersion (QTd) is prolonged, correlating with high intracellular magnesium. In patients with cardiac disorders, renin-angiotensin system (RAS) inhibition reduces QTd.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1660-2110
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright (c) 2006 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
c176-84
|
|
pubmed:meshHeading |
pubmed-meshheading:17003569-Aged,
pubmed-meshheading:17003569-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:17003569-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:17003569-Calcium,
pubmed-meshheading:17003569-Cilazapril,
pubmed-meshheading:17003569-Female,
pubmed-meshheading:17003569-Heart Rate,
pubmed-meshheading:17003569-Humans,
pubmed-meshheading:17003569-Kidney Failure, Chronic,
pubmed-meshheading:17003569-Magnesium,
pubmed-meshheading:17003569-Male,
pubmed-meshheading:17003569-Middle Aged,
pubmed-meshheading:17003569-Renal Dialysis,
pubmed-meshheading:17003569-Renin-Angiotensin System,
pubmed-meshheading:17003569-Tetrazoles,
pubmed-meshheading:17003569-Valine
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Blockade of renin-angiotensin system reduces QT dispersion and improves intracellular Ca/Mg status in hemodialysis patients.
|
|
pubmed:affiliation |
Nephrology Division, Assaf Harofeh Medical Center, Affiliated to Sackler Medical School, Tel Aviv University, Zerifin, Israel. averbukhzh@asaf.health.gov.il
|
|
pubmed:publicationType |
Journal Article,
In Vitro,
Controlled Clinical Trial
|
